Search

Your search keyword '"Roukema J"' showing total 397 results

Search Constraints

Start Over You searched for: Author "Roukema J" Remove constraint Author: "Roukema J"
397 results on '"Roukema J"'

Search Results

2. FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

3. P163 Reliability, reproducibility, and responsiveness of home spirometry in regular cystic fibrosis care

4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

6. Home monitoring in asthma: towards digital twins

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

8. FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.

9. Maternal depressive symptoms during pregnancy and infant wheezing up to 2 years of age.

10. FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

12. FDA-Approved Drug Screening in Patient-Derived Organoids Demonstrates Potential of Drug Repurposing for Rare Cystic Fibrosis Genotypes

13. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

19. Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression

20. Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients

21. 665: Forskolin-induced intestinal organoid swelling predicts long-term cystic fibrosis disease progression

22. 563: Real-life initiation of elexacaftor/ivacaftor/tezacaftor in cystic fibrosis patients with severe lung disease

23. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

25. Forskolin-induced swelling of intestinal organoids predicts long-term cystic fibrosis disease progression

27. It Is Not Just the FEV1 That Matters, but the Personal Goals We Reach Along the Way: Qualitative, Multicenter, Prospective, Observational Study

31. Forskolin-induced swelling of intestinal organoids predicts long-term cystic fibrosis disease progression

36. eHealth in paediatric asthma. From promise to practice

37. Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation

50. Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Catalog

Books, media, physical & digital resources